The Research Luxembourg COVID-19 task force announces the start of “Predi-COVID ”, a study that aims to identify important risk factors and biomarkers associated with COVID-19 severity and long-term health consequences of the disease in Luxembourg.

André Losch Fondation announced its participation in the fight against the COVID-19 pandemic by supporting Research Luxembourg with one of its most significant donations yet. The foundation’s commitment of 1,4 million euros will help financing three COVID-19 studies currently underway in Luxembourg: the CON-VINCE study, aiming to evaluate the dynamics of the spread of the disease within Luxembourg; the Predi-COVID study, dedicated to finding predictive markers for disease severity; and a study that develops statistical projections and modelling of the epidemic. On top of this André Losch Fondation will also provide financing for four vans that will allow nurses to collect tissue samples of study participants, thereby sparing them a trip to the hospital.

Dr Chantal Snoeck is a scientist within the Clinical and Applied Virology of the LIH Department of Infection and Immunity.

Prof Markus Ollert is the Director of the LIH Department of Infection and Immunity. As a medical doctor and researcher, he exemplifies the “clinician scientist” profile, bringing both his healthcare and research experience to the table in order to unravel the processes underlying the onset of immune-related diseases.

The Research Luxembourg COVID-19 task force announces the launch of “CON-VINCE ”, a study that aims to evaluate the dynamics of the spread of the COVID-19 disease within the Luxembourgish population.

‘Research Luxembourg’, the initiative of the main players of Luxembourg public research, has launched its website.

Prof Dirk Brenner (DB) is Deputy Head of Research & Strategy and leads the Experimental and Molecular Immunology research group at the LIH Department of Infection and Immunity.

COVID-19 taskforce: Launch of national platform, FNR Call in the making